Gainers
• Innovate, Inc. INNT shares surged 72.1% to $1.13 during Thursday's pre-market session.
• Altimmune, Inc. ALT shares moved upwards by 17.4% to $2.36.
• Novavax, Inc. NVAX stock increased by 13.5% to $8.05.
• Ocugen, Inc. OCGN stock surged 7.5% to $0.76. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
Losers
• Applied Genetic Tech, Inc. AGTC stock fell 23.4% to $7.55 during Thursday's pre-market session.
• Tetraphase Pharmaceutical, Inc. TTPH shares fell 22.1% to $2.99. The most recent rating by Gabelli & Co., on October 31, is at Buy, with a price target of $5.00.
• Karuna Therapeutics, Inc. KRTX shares fell 13.5% to $99.73. The most recent rating by Wells Fargo, on January 22, is at Overweight, with a price target of $137.00.
• Trillium Therapeutics, Inc. TRIL shares plummeted 10.6% to $2.92.
• Titan Pharmaceuticals, Inc. TTNP stock decreased by 9.1% to $0.30.
• Genfit, Inc. GNFT shares decreased by 7.8% to $18.60. The most recent rating by HC Wainwright & Co., on October 31, is at Buy, with a price target of $58.00.
• Genprex, Inc. GNPX shares decreased by 7.4% to $1.75.
• Immunogen, Inc. IMGN stock declined 6.0% to $4.40.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.